SEC Filing

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

SEC Filing Details

Document Details

Filing Date
Feb 10, 2022
Document Date
Feb 10, 2022
Form Description
An amendment to the SC 13G filing
Filing Group
Other
Company
Jazz Pharmaceuticals plc
Issuer
JAZZ PHARMACEUTICALS PLC